Keywords: btg, collegium, develop, new, asthma, drug, london

BTG and Collegium to develop new asthma drug

Article | 05 September 2005

London, UK-based medical innovations firm, BTG, and USA-headquartered Collegium Pharmaceutical have signed a joint collaboration agreement to develop CP-141, a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in